Correspondingly, ESCC cells underwent treatment with the LDHA selective inhibitor GSK2837808A (15 μM) for a span of 24 hours aimed at suppressing LDHA expression (Fig. 6A). Here, LDHA is linked to esophageal squamous cell carcinoma.